DRUG STUDY OF ERCEFLORA

Name: Mary Relator

Age: 1 year old
Case: CAP
Generic Name: bacillus clausii

Brand Name: Erceflora

Classification: Antidiarrheals

Suggested Dose:

Adults 2-3 vials of 2 billion/5 mL susp

Children 2-11 years 1-2 vials of 2 billion/5 mL susp

Infants >1 month 1-2 vials of 2 billion/5 mL susp.

Mode of Action:

Contributes to the recovery of the intestinal microbial flora altered during
the course of microbial disorders of diverse origin. It produces various
vitamins, particularly group B vitamins thus contributing to correction of
vitamin disorders caused by antibiotics & chemotherapeutic agents.
Promotes normalization of intestinal flora.

Indication:

Acute diarrhea with duration of 14 days due to infection, drugs or poisons.
Chronic or persistent diarrhea with duration of >14 days.

Contraindication:
Not for use in immunocompromised patients (cancer patients on
chemotherapy, patients taking immunosuppressant meds)

Drug Interaction: No known drug interactions.

Side Effects: No known side effects.

Adverse Effects: No known adverse effects.

DRUG STUDY OF ALBUTEROL SULFATE
Name: John Relator
Age: 11 months
Case: Acute Gastroenteritis with Moderate Dehydration PCAP with (CAP-MR)
Generic Name: albuterol sulfate

Brand Name: Proventil

Functional Class: Antiasthmatic, Bronchodilator
Mechanism of Action: In low doses, acts relatively selectively at
beta2adrenergic receptors to cause bronchodilation and vasodilation; at
higher doses; beta2selectivity is lost, and the drug acts at beta2 receptors to
cause typical sympathomimetic cardiac effects.
Indications:
Inhalation: Treatment of acute attacks of bronchospasm
Prevention of exercise-induced bronchospasm
Contraindications:
Contraindicated with hypersensitivity to albuterol; tachyarrhythmias,
tachycardia caused by digitalis intoxication; general anesthesia with
halogenated hydrocarbons or cyclopropane )these synthesize the
myocardium to catecholamines); unstable vasomotor system
disorders;hypertension; coronary insufficiency, CAD; history of CVA;
COPD patients with degenerative heart disease.
Actual Dose: 1 neb q 6
Actual Indication: Treatment of acute attacks of bronchospasm.
Interactions:
Drug-drug: Increased sympathomimetic effects with other
sympathomimetic drugs.
Increased risk of toxicity, especially cardiac, when used with
theophylline, aminophylline.
Decreased bronchodilating effects with beta-adrenergic blockers (eg,
propranolol)
Decreased effectiveness of insulin, oral hypoglycemic drugs.
Decreased serum levels and therapeutic effects of digoxin.
Side Effects: Dizziness, drowsiness, fatigue, headache, nausea, vomiting,
anxiety, sweating, flushing, rapid heart rate
Adverse Effects:
CNS: Hyperkinesia, insomnia, tremor, irritability, vertigo
GI: Heartburn, unusual or bad taste in mouth
DERMATOLOGIC: Pallor
RESPIRATORY: Respiratory difficulties, pulmonary edema, coughing,
bronchospasm; paradoxical airway resistance with repeated, excessive use
of inhalation preparations
Nursing Considerations:
Use miminal doses for minimal periods; drug tolerance can occur with
prolonged used.
Do not exceed recommended dosage; administer pressurized
inhalation drug forms during second half of inspiration, because the
airways are open wider and the aerosol distribution is more extensive.
Pregnancy Category: C
Patient Teaching:
Advise SO to do not exceed recommended dosage; adverse effects or
loss of effectiveness may result. Read the instructions that come with
respiratory inhalant.
Advise SO to report if the patient has chest pain, dizziness, insomnia,
weakness, or tremors or irregular heartbeat, DOB, productive cough,
failure to respond to usual dose.
RATIONALE:
This drug was given to this patient because he has pneumonia which
causes him to have DOB. This drug is to give him comfort and to breath
normally.